Liquid Biopsy Market Status – Size, Top Companies, Annual Forecast

Posted by vinit sawant on February 3rd, 2021

According to the new MRFR report, such factors include growing awareness regarding the diagnosis of different types of cancer, multiple benefits of liquid biopsy such as less labor required, low cost, identification of specific mutations, and quick analysis, and extensive R&D in the diagnosis and treatment of cancer. Besides, the rising prevalence of cancer and burgeoning demand for non-invasive testing are also adding market growth.

On the contrary, tumor heterogeneity being the biggest challenge in cancer research may limit the global liquid biopsy market growth over the forecast period. Besides, the production process in its entirety being adversely impacted due to the temporary shutdown of industries and complete lockdown following the COVID-19 pandemic that has limited the overall blood collection tubes for the global liquid biopsy market is also hindering the market growth.

Market Segmentation

The MRFR report gives an inclusive segmental analysis of the global liquid biopsy market report based on end user, samples, application, and types.

By types, the global liquid biopsy market is segmented into extracellular vehicles (EVS), circulating tumor DNA (CTDNA), circulating tumor cells (CTCS), and others. Of these, the circulating tumor cells segment will lead the market over the forecast period.